stock split
Bluejay Diagnostics to Execute 1-for-8 Reverse Stock Split
The firm currently offers its rapid Symphony platform for near-patient testing in critical care settings.
OpGen to Execute 1-for-10 Reverse Stock Split
The reverse stock split is intended to bring the firm back into compliance with the Nasdaq's minimum bid price listing requirement of $1.00 per share.
In Brief This Week: Abbott; Devyser; Virax Biolabs; DnaNudge; PharmaKure
News items for the week of Dec. 11, 2023.
Prenetics to Execute 1-for-15 Reverse Stock Split
The move, which will take effect Nov. 13, is intended to bring the company back into compliance with Nasdaq's minimum bid listing requirement of $1 per share.
T2 Biosystems Shares Plummet After Reverse Split
The firm had effected the reverse split in order to regain compliance with Nasdaq regulations.
Jul 24, 2023
Oncocyte Initiates 1-for-20 Reverse Stock Split
Apr 28, 2023
GeneDx to Execute 1-for-33 Reverse Stock Split
Jan 5, 2023
OpGen Announces 1-for-20 Reverse Stock Split
Nov 23, 2020
HTG Molecular Completes 1-For-15 Reverse Stock Split
Aug 28, 2019
OpGen Plans Reverse Stock Split
Apr 26, 2019
Precipio to Effect 1-for-15 Reverse Stock Split
Jan 17, 2018
OpGen to Execute 1-for-25 Reverse Stock Split
Mar 16, 2017
Rosetta Genomics Announces Reverse Stock Split
Dec 28, 2016
Interpace Effecting a 1-for-10 Reverse Stock Split
Dec 23, 2016